ARTICLE | Company News
Biota, GlaxoSmithKline infectious news
August 22, 2005 7:00 AM UTC
Germany placed an order for 1.7 million packs of inhaled influenza drug Relenza zanamavir through BTA partner GSK. Governments have been considering early use of neuraminidase inhibitors, including Relenza and Tamiflu oseltamivir from Gilead Sciences Inc. (GILD, Foster City, Calif.) and Roche (SWX:ROCZ, Basel, Switzerland), in the event of an influenza pandemic. ...